Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03760796 · ClinicalTrials.gov registry record · NA

Myocardial Infarction, COmbined-device, Recovery Enhancement Study

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT03760796: Completed NA study, sponsored by Johns Hopkins University.

NCT03760796 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03760796, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

Unplanned readmissions after hospitalization for acute myocardial infarction (AMI) are among the leading causes of preventable morbidity, mortality, and healthcare costs. Digital health interventions (DHI) could be an effective tool in promoting self-management, adherence to guideline directed therapy, and cardiovascular risk reduction. A DHI developed at Johns Hopkins-the Corrie Health Digital Platform-includes the first cardiology Apple CareKit smartphone application, paired with an Apple Watch and iHealth Bluetooth-enabled blood pressure monitor. Corrie targets: (1) self-management of cardiac medications, (2) self-tracking of vital signs, (3) education about cardiovascular disease through articles and animated videos, and (4) care coordination that includes cardiac rehabilitation and outpatient follow-up appointments. In this prospective study, STEMI or type 1 NSTEMI patients are being enrolled to use the Corrie Health Digital Platform beginning early during participants' hospital stay. Enrollment sites include Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center, Massachusetts General Hospital, and Reading Hospital. The primary objective is to compare time to first readmission within 30 days post-discharge among patients with the Corrie Health Digital Platform to patients in the historical standard of care comparison group.

Interventions

  • DEVICE Corrie Health Digital Platform

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2016-10-01
Est. Completion 2019-12-17
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03760796

The ClinicalTrials.gov registry entry for NCT03760796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Corrie Health Digital Platform is the first listed.

NCT03760796 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03760796 about?

NCT03760796 is a clinical study titled "Myocardial Infarction, COmbined-device, Recovery Enhancement Study". Unplanned readmissions after hospitalization for acute myocardial infarction (AMI) are among the leading causes of preventable morbidity, mortality, and healthcare costs. Digital health interventions (DHI) could be an effective tool in promoting self-management, adherence to guideline directed thera...

What is the current status of trial NCT03760796?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2016-10-01. Estimated completion is 2019-12-17.

What interventions are being tested in trial NCT03760796?

The interventions under investigation include: Corrie Health Digital Platform (DEVICE).

Who is sponsoring clinical trial NCT03760796?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.